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http://dxObjective: Whether patients with bicuspid aortic valves are susceptible not only to ascending aortic dilatation
but also to dilatation of the remaining aorta is uncertain. This study evaluated the possible correlation between
ascending aortic dilatation and dilatation of the remaining aorta in patients with bicuspid and tricuspid aortic
valves, respectively.
Methods:The entire aortas of 97 patients (bicuspid in 62, tricuspid in 35) undergoing replacement of the ascend-
ing aorta because of ascending aortic pathology (78 with and 19 without concurrent valve pathology) were pre-
operatively evaluated using computed tomography scanning.
Results:Aortic dimensions distal to the ascending aorta were smaller in patients with bicuspid aortic valves than
in patients with tricuspid aortic valves (P<.001): proximal arch: 3.20  0.60 cm/3.80  0.68 cm; distal arch:
2.90  0.60 cm/3.40  0.50 cm; isthmus, 2.95  0.60 cm/3.50  0.60 cm; descending aorta: 2.70  0.50 cm/
3.20 0.65 cm; suprarenal aorta: 2.30 0.40 cm/2.70 0.43 cm; infrarenal aorta: 1.90 0.48 cm/2.20 0.35
cm, respectively. Concomitant pathologic dilatation of the descending aorta was more common in patients with
tricuspid aortic valves (37%) than in patients with bicuspid aortic valves (5%) (P<.001). Neither valvular pa-
thology nor bicuspid aortic valve phenotype influenced the aortic dimensions in the bicuspid group (P>.2).
Conclusions: Patients with bicuspid aortic valves and dilatation of the ascending aorta consistently had smaller
dimensions of the remaining aorta compared with patients with tricuspid aortic valves. Concomitant dilatation of
the descending aorta was predominantly found in patients with tricuspid aortic valves. (J Thorac Cardiovasc
Surg 2013;146:605-10)A
C
DBicuspid aortic valve (BAV) is a common cardiac malfor-
mation occurring in 0.5% to 2% of the population. Patients
with BAV present with valvular pathology (ie, stenosis or
regurgitation) earlier in life than patients with tricuspid aor-
tic valve (TAV) and are predisposed to dilatation and dissec-
tion of the ascending aorta. Thus, BAVentails an increased
risk of morbidity and mortality.1
The underlying mechanisms of ascending aortic dilata-
tion in patients with BAV are still a matter of debate. The
susceptibility to development of ascending aortic pathology
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The Journal of Thoracic and Caa congenital defect involving the ascending aortic wall or
the result of altered blood flow patterns due to BAV mor-
phology.2,3 There is still disagreement on the optimal
treatment strategy and long-term follow-up regimen of pa-
tients with BAV with aortic dilatation.4,5 There are data
suggesting partly similar molecular mechanisms in
ascending aortic aneurysm formation in patients with
BAV, as in patients with Marfan syndrome.6 Patients with
Marfan syndrome are at risk of developing aortic pathology
of the distal aorta,7 which raises the question if the same is
true for patients with BAV.
Reports of evaluation of the entire aorta in patients with
BAV are scarce. Therefore, the aim of this study was to in-
vestigate whether there is a relation between ascending aor-
tic dilatation in patients with BAV who underwent
ascending aortic surgery and concomitant dilatation of the
remaining aorta and a further comparison of BAV and
TAV in this respect.MATERIALS AND METHODS
Patients
The study population consisted of 97 patients (BAV in 62, TAV in 35)
undergoing elective heart surgery between February 13, 2007, and Febru-
ary 12, 2012. These patients were studied in the setting of the Advanced
Study of Aortic Pathology, a prospective, single-center, observational co-
hort study of patients with aortic valve or ascending aortic disease with
an indication for elective surgery (n ¼ 500).8 The present retrospectiverdiovascular Surgery c Volume 146, Number 3 605
TABLE 1. Patient characteristics according to valvular morphology
TAV
(n ¼ 35)
BAV
(n ¼ 62) P value
Age (y) 63  12 59  13 .084
Gender, n (M/F) 22/13 42/20 >.2
BSA 2.00  0.27 1.96  0.22 >.2
BMI 27  3 26  4 >.2
Hypertension,* n 24 36 >.2
Diabetes,* n 0 2 >.2
CVL (preoperative), n 2 2 >.2
COPD,* n 0 1 >.2
Normal valve, n (%) 6 (17) 13 (21) >.2
Aortic stenosis, n (%) 0 21 (34) <.001
Aortic regurgitation, n (%) 29 (83) 28 (45) <.001
Values are given as mean  standard deviation, frequency (n), or percentage (%).
TAV, Tricuspid aortic valve; BAV, bicuspid aortic valve; BSA, body surface area;
BMI, body mass index; CVL, cerebrovascular lesion; COPD, chronic obstructive pul-
monary disease. *As defined by ongoing medical treatment.
Abbreviations and Acronyms
BAV ¼ bicuspid aortic valve
BSA ¼ body surface area
CT ¼ computed tomography
TAV ¼ tricuspid aortic valve
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ing aorta (n¼ 97) in combination with aortic valve stenosis (n¼ 21), aortic
valve regurgitation (n ¼ 57), or a normally functioning valve (n ¼ 19), all
of whom had undergone preoperative examination of the entire aorta by
computed tomography (CT). Patients with Marfan syndrome were ex-
cluded. Definite valve phenotype (TAVor BAV) was determined intraoper-
atively. The patient characteristics are summarized in Table 1.
Surgical Procedure
All patients underwent operation in a standardized fashion as previously
described.8 A supracoronary graft was used alone (n ¼ 18) or in combina-
tion with a mechanical valve prosthesis (n¼ 5), a biological valve prosthe-
sis (n ¼16), aortic valve plasty (n ¼ 5), a biological composite graft
(Medtronic Freestyle, Medtronic Inc, Minneapolis, Minn) (n ¼ 16), or
arch surgery (n ¼ 2). A mechanical valved graft (St Jude Medical, Inc,
St Paul, Minn) (n ¼ 14) or a biological composite graft (Medtronic Free-
style) (n ¼ 5) alone was used in 19 patients, and reimplantation ad modum
David (n¼ 12) alone or in combination with aortic valve plasty (n¼ 4) was
used in 16 patients.
Computed Tomography Examination
The local hospital protocol for CT examinations was followed. Eighty
milliliters of contrast medium (300 mg iodine per mL, Omnipaque, GE
Healthcare, Ltd, Little Chalfont, UK) was administrated into an antecubital
vein at a flow rate of 4 mL/s using a power injector. The delay time for the
images was determined by bolus-tracking. All CT images were reviewed
by a single experienced external radiologist blinded to aortic valve mor-
phology and subsequent surgical procedure. Maximal outer wall measure-
ments were obtained in the axial plane in the following sections of the
aorta: aortic annulus, sinus of Valsalva, sinotubular junction, ascending
aorta, proximal arch, distal arch, aortic isthmus, descending aorta, suprare-
nal aorta, and infrarenal aorta (Figure 1 and Table 2).
Definitions
The evaluation and definition of valvular morphology (ie, TAVor BAV,
including BAV phenotype) and aortic valve pathology (ie, aortic valve ste-
nosis or aortic valve regurgitation) used in this study have been described.8
The indication for ascending aortic surgery with or without concomitant
valve replacement/reconstruction was based on current surgical guide-
lines,9 but it was ultimately at the surgeon’s discretion. The descending
aorta and the infrarenal aorta were considered dilated at the diameters sug-
gested and described by Wanhainen and colleagues10 (descending aorta 
3.7 cm in men and 3.3 cm in women; infrarenal aorta  3.0 cm in men
and 2.7 cm in women).
Ethical Approval
The study was approved by the regional Human Research Ethics
Committee. Oral and written consent were obtained from all patients.
Statistical Analysis
Continuous variables are given as mean with standard deviation or me-
dian with interquartile range as appropriate, and categorical variables are
presented as frequency and percentage. Mann–Whitney U test or Student t606 The Journal of Thoracic and Cardiovascular Surgtest was used for comparisons between continuous data as appropriate.
The Fisher exact test was used for comparison of categorical data. For
comparisons of the aortic diameters in patients with BAV shown in
Tables 3 and 4, Kruskall–Wallis 1-way analysis of variance was used.
In Table 3, the between-group factor was ‘‘valve pathology’’ with 3 levels
(normal valve, aortic stenosis, and aortic regurgitation). In Table 4, the
between-group factor was ‘‘BAV phenotype’’ with 3 levels (fusion of
the right and left coronary cusps, fusion of the right and noncoronary
cusps, and true BAV). Analysis of covariance was also used in compari-
sons between patients with BAV and patients with TAV to adjust for
age, gender, body surface area (BSA), and comorbidities. Statistical anal-
yses were performed using StatView software (v 5.0.1; SAS Institute Inc,
Cary, NC).RESULTS
Of the 97 patients, all undergoing heart surgery because
of dilatation of the ascending aorta, 64% had BAV
(n ¼ 62) and 36% had TAV (n ¼ 35). Patients with BAV
and TAVwere comparable with regard to preoperative char-
acteristics. However, the distribution of aortic valve pathol-
ogy differed between the groups. Aortic valve stenosis was
found only in patients with BAV, whereas aortic valve regur-
gitation was more common in patients with TAV (Table 1).
In the BAV group, 48 patients (77%) had fusion of the right
and left coronary cusps, 8 patients (13%) had fusion of the
right and noncoronary cusps, and 6 patients (10%) had
a true BAV.Dimensions of the Aortic Arch, Descending Aorta,
and Abdominal Aorta
No differences in aortic dimensions at the level of the an-
nulus, the sinus of Valsalva, the sinotubular junction, or the
ascending aorta were found when comparing the BAV and
TAV groups. The dimensions of the proximal arch, distal
arch, aortic isthmus, descending aorta, suprarenal aorta,
and infrarenal aorta were consistently smaller in patients
with BAV in comparison with patients with TAV (Table 2).ery c September 2013
FIGURE 1. Schematic illustration of the aortic measure points:
1 ¼ annulus; 2 ¼ sinus of Valsalva; 3 ¼ sinotubular junction;
4¼ ascending aorta (ie, maximal aortic width distal to the sinotubular junc-
tion and proximal to the innominate artery); 5 ¼ proximal aortic arch (ie,
maximal aortic width distal to the innominate artery and proximal to the
left common carotid artery); 6¼ distal aortic arch (ie, maximal aortic width
distal to the left common carotid artery and proximal to the left subclavian
artery); 7¼ aortic isthmus; 8¼ descending aorta (ie, maximal aortic width
distal to the aortic isthmus and proximal to the diaphragm); 9¼ suprarenal
aorta (ie, maximal aortic width distal to the coeliac trunk and proximal to
the superior mesenteric artery); 10 ¼ infrarenal aorta (ie, maximal aortic
width distal to the most caudal renal artery).
TABLE 2. Aortic dimensions according to valvular morphology
TAV
(n ¼ 35)
BAV
(n ¼ 62) P value
Annulus 2.40 (0.40)
[1.19 (0.23)]
2.50 (0.40)
[1.27 (0.19)]
>.2
.054
Sinus of Valsalva 4.30 (1.75)
[2.14 (0.63)]
4.10 (0.80)
[2.16 (0.40)]
>.2
>.2
Sinotubular junction 4.30 (1.18)
[2.06 (0.48)]
3.85 (0.90)
[1.97 (0.41)]
.057
.085
Ascending aorta 5.30 (0.78)
[2.76 (0.91)]
5.20 (0.40)
[2.60 (0.43)]
.108
>.2
Proximal arch 3.80 (0.68)
[1.92 (0.64)]
3.20 (0.60)
[1.68 (0.43)]
<.001
.014
Distal arch 3.40 (0.50)
[1.77 (0.50)]
2.90 (0.60)
[1.52 (0.25)]
<.001
<.001
Aortic isthmus 3.50 (0.60)
[1.79 (0.54)]
2.95 (0.60)
[1.53 (0.30)]
<.001
<.001
Descending aorta 3.20 (0.65)
[1.59 (0.66)]
2.70 (0.50)
[1.36 (0.26)]
<.001
<.001
Suprarenal aorta 2.70 (0.43)
[1.33 (0.52)]
2.30 (0.40)
[1.15 (0.19)]
<.001
.002
Infrarenal aorta 2.20 (0.35)
[1.11 (0.32)]
1.90 (0.48)
[0.92 (0.21)]
<.001
.022
Values are given as median with interquartile range, in centimeters for diameters, and
as centimeter per square meter for diameter indexed to BSA (values within square
brackets). TAV, Tricuspid aortic valve; BAV, bicuspid aortic valve.
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DAortic Dimensions in Relation to Valvular Pathology
and Bicuspid Aortic Valve Phenotype
When analyzing the aortic dimensions according to val-
vular pathology (ie, normal function, stenosis, or regurgita-
tion), no differences were found within the BAV group. At
the level of the annulus, sinus of Valsalva, and sinotubular
junction, patients with TAV and a regurgitant valve had
larger crude aortic dimensions compared with patients
with normal valve function. When BSAwas taken into con-
sideration, patients with TAV with valve regurgitation still
had larger aortic dimensions at the level of the sinus of Val-
salva, sinotubular junction, and distal arch, but not at the
level of the annulus (Table 3).
No differences in aortic dimensions within the BAV
group were detected on the basis of valve phenotype, that
is, fusion of the right and left coronary cusps, fusion of
the right and noncoronary cusps, or true BAV (Table 4).Concomitant Dilatation of the Descendning Aorta
and/or Infrarenal Aorta
Dilatation of the descending aorta was found in 13 pa-
tients (37%) with TAV and 3 patients (5%) with BAV. Di-
latation of the infrarenal aorta was found in 3 patients
(9%) with TAV and 5 patients (8%) with BAV. Dilatation
of the descending aorta and the infrarenal aorta was found
in 2 patients with TAVand 1 patient with BAV, respectively.
Thus, concomitant dilatation of the descending aorta was
more common in the TAV group than in the BAV grouprdiovascular Surgery c Volume 146, Number 3 607
TABLE 3. Aortic dimensions according to valve pathology
BAV TAV
Valve stenosis
(n ¼ 21)
Valve regurgitation
(n ¼ 28)
Normal valve
(n ¼ 13) P value
Valve regurgitation
(n ¼ 29)
Normal valve
(n ¼ 6) P value
Annulus 2.60 (0.45)
[1.31 (0.23)]
2.50 (0.33)
[1.20 (0.17)]
2.40 (0.20)
[1.26 (0.12)]
>.2
.097
2.50 (0.45)
[1.22 (0.23)]
2.20 (0.30)
[1.16 (0.10)]
.040
>.2
Sinus of Valsalva 4.00 (0.53)
[2.08 (0.33)]
4.20 (0.75)
[2.17 (0.30)]
4.10 (1.10)
[2.23 (0.78)]
>.2
>.2
4.60 (1.50)
[2.20 (0.61)]
3.45 (0.80)
[1.89 (0.06)]
.007
.006
Sinotubular junction 3.70 (0.70)
[1.93 (0.30)]
3.90 (0.90)
[2.00 (0.38)]
3.90 (1.00)
[2.01 (0.46)]
>.2
>.2
4.40 (0.88)
[2.10 (0.42)]
3.25 (0.60)
[1.83 (0.20)]
.003
.002
Ascending aorta 5.10 (0.58)
[2.59 (0.37)]
5.20 (0.40)
[2.60 (0.49)]
5.30 (0.28)
[2.76 (0.31)]
.153
>.2
5.30 (0.98)
[2.52 (0.98)]
5.70 (0.70)
[2.87 (0.59)]
>.2
>.2
Proximal arch 3.50 (0.53)
[1.75 (0.44)]
3.20 (0.53)
[1.60 (0.38)]
3.25 (0.45)
[1.77 (0.29)]
.093
.066
3.80 (0.70)
[1.87 (0.65)]
3.85 (1.10)
[2.09 (0.27)]
>.2
.111
Distal arch 3.00 (0.70)
[1.57 (0.29)]
2.90 (0.55)
[1.50 (0.33)]
2.90 (0.38)
[1.53 (0.13)]
>.2
>.2
3.30 (0.43)
[1.74 (0.44)]
3.60 (1.30)
[1.93 (0.60)]
.115
.034
Aortic isthmus 2.90 (0.63)
[1.52 (0.33)]
2.95 (0.70)
[1.49 (0.38)]
3.00 (0.50)
[1.54 (0.21)]
>.2
>.2
3.50 (0.70)
[1.77 (0.53)]
3.60 (1.40)
[2.01 (0.46)]
>.2
.115
Descending aorta 2.60 (0.60)
[1.37 (0.25)]
2.80 (0.55)
[1.34 (0.29)]
2.70 (0.33)
[1.38 (0.19)]
>.2
>.2
3.20 (0.63)
[1.55 (0.60)]
3.50 (1.00)
[1.92 (0.56)]
.063
.054
Suprarenal aorta 2.30 (0.43)
[1.19 (0.22)]
2.30 (0.40)
[1.12 (0.19)]
2.30 (0.30)
[1.16 (0.12)]
>.2
>.2
2.70 (0.40)
[1.27 (0.48)]
2.80 (0.70)
[1.58 (0.39)]
.102
.056
Infrarenal aorta 1.80 (0.35)
[0.87 (0.11)]
1.90 (0.45)
[0.95 (0.32)]
1.85 (0.30)
[0.91 (0.10)]
>.2
>.2
2.20 (0.40)
[1.10 (0.34)]
2.35 (0.50)
[1.14 (0.15)]
>.2
>.2
Values are given as median with interquartile range, in centimeters for diameters, and as centimeter per square meter for diameter indexed to BSA (values within square brackets).
BAV, Bicuspid aortic valve; TAV, tricuspid aortic valve.
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aorta alone and in combination with dilatation of theTABLE 4. Aortic dimensions according to bicuspid aortic valve
phenotype
RL
(n ¼ 48)
RN
(n ¼ 8)
True BAV
(n ¼ 6) P value
Annulus 2.50 (0.38)
[1.27 (0.21)]
2.55 (0.30)
[1.27 (0.15)]
2.55 (0.40)
[1.31 (0.21)]
>.2
>.2
Sinus of Valsalva 4.10 (0.70)
[2.13 (0.40)]
4.10 (0.40)
[2.08 (0.39)]
4.75 (1.30)
[2.23 (0.44)]
>.2
>.2
Sinotubular junction 3.75 (0.90)
[1.96 (0.42)]
4.00 (0.75)
[1.98 (0.34)]
4.10 (0.60)
[2.06 (0.23)]
>.2
>.2
Ascending aorta 5.20 (0.40)
[2.61 (0.40)]
5.25 (0.75)
[2.61 (0.37)]
4.95 (0.50)
[2.53 (0.56)]
>.2
>.2
Proximal arch 3.20 (0.60)
[1.64 (0.42)]
3.50 (0.43)
[1.75 (0.23)]
3.10 (1.30)
[1.71 (0.61)]
.136
>.2
Distal arch 2.90 (0.55)
[1.50 (0.29)]
3.25 (0.40)
[1.63 (0.20)]
2.90 (0.80)
[1.54 (0.23)]
>.2
>.2
Aortic isthmus 2.95 (0.60)
[1.53 (0.32)]
3.25 (0.75)
[1.55 (0.16)]
2.85 (0.60)
[1.46 (0.16)]
>.2
>.2
Descending aorta 2.70 (0.60)
[1.36 (0.26)]
2.85 (0.50)
[1.38 (0.11)]
2.65 (0.20)
[1.31 (0.18)]
>.2
>.2
Suprarenal aorta 2.30 (0.43)
[1.15 (0.20)]
2.45 (0.30)
[1.16 (0.07)]
2.30 (0.20)
[0.15 (0.23)]
>.2
>.2
Infrarenal aorta 1.90 (0.50)
[0.91 (0.31)]
1.80 (0.43)
[0.94 (0.10)]
1.85 (0.25)
[0.86 (0.06)]
>.2
>.2
Values are given as median with interquartile range, in centimeters for diameters, and
as centimeter per square meter for diameter indexed to BSA (values within square
brackets). RL, Right and left coronary cusp fusion; RN, right and noncoronary cusp
fusion; BAV, bicuspid aortic valve.
608 The Journal of Thoracic and Cardiovascular Surgdescending aorta was equally common in both groups (P
> .2 in both instances).DISCUSSION
In this study of 97 patients with dilated ascending aorta
undergoing ascending aortic surgery because of ascend-
ing aortic pathology with or without concomitant valvu-
lar pathology, patients with BAV consistently had
smaller arch, descending, suprarenal, and infrarenal aor-
tic dimensions than patients with TAV. Furthermore, pa-
tients with TAV had concomitant pathologic dilatation
of the descending aorta to a greater extent than patients
with BAV. There were no differences in aortic root and
ascending aortic dimensions between the BAV and TAV
groups. In addition, neither valvular pathology nor BAV
phenotype influenced the aortic dimensions in the BAV
group, which is in accord with previous findings of the
lack of relation between BAV phenotype and aortic root
morphology.8
Analysis of covariance was used to adjust for age, gender,
BSA, and certain comorbidities, and the differences in aor-
tic dimensions found between BAV and TAV groups could
not be assigned to these factors. There were no detectable
differences in aortic dimensions related to valvular pathol-
ogy when analyzing the BAV group alone, and only minor
differences in aortic root dimensions were found in the
TAV group in relation to a normally functioning or regurgi-
tant valve (Tables 3 and 4).ery c September 2013
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dilatation had smaller dimensions of the remaining aorta
than patients with TAV is in agreement with previous echo-
cardiographic evaluation of individuals with BAV who did
not undergo surgery. Cecconi and co-workers11 retrospec-
tively evaluated, using transthoracic echocardiography,
the dimensions of the entire aorta in 162 patients with
BAVwithout valvular pathology and stratified them accord-
ing to age. They found a prevalence of 28% to 77% of as-
cending aortic dilatation in the different age strata but could
not find any relation between BAVand dilatation of the de-
scending or abdominal aorta. Our data could not confirm the
findings by Fazel and colleagues12; in their study, 28% of
patients with BAV with dilated ascending aorta also had
concomitant dilatation of the transverse arch. However, it
should be pointed out that a direct comparison is difficult
to make because of differences in measure points and
method of analysis. Alegret and colleagues13 have reported
different profiles of aortic diameter in relation to valvular
morphology based on CT examinations of the aorta in 71
patients with dilated aortic root primarily identified by
echocardiography. The authors pointed out a high preva-
lence of concomitant abdominal aortic aneurysms in pa-
tients aged more than 60 years with TAV but not BAV.
Conversely, Larsson and colleagues14 reported that patients
with abdominal aortic aneurysms had a high frequency of
thoracic aortic aneurysm mainly located in the descending
part of the thoracic aorta, although the relative distribution
of BAVand TAV was unknown in their study. In our cohort
of patients, all of whom underwent operation for a dilated
ascending aorta, concomitant pathologic dilatation of the
descending aorta was more common in patients with TAV
than in patients with BAV (37% vs 5%). Taken together,
these findings support that BAV-associated dilatation of
the aorta is present in the aortic root and/or ascending aorta
but not in the descending or abdominal aorta.11 In contrast,
dilatation of the aorta in patients with TAV can be present in
all aortic segments.
The underlying pathologic mechanisms of aortic aneu-
rysm formation are multifaceted. Aortic aneurysms, regard-
less of location (ie, ascending, descending, or abdominal),
are associated with medial degeneration, which is charac-
terized by loss of elastic fibers and smooth muscle cells. In-
flammation and atherosclerosis are highly associated with
abdominal aortic aneurysm, which is to some extent a factor
in descending aortic aneurysm formation but not a major
contributor to aneurysm formation of the ascending aorta.15
To complicate the matter, the histopathologic and genetic
features of descending and abdominal aortic aneurysms dif-
fer.16 Moreover, mediators of medial degeneration6,17 and
activation of immune response18 in aneurysm formation
of the ascending aorta differ between patients with BAV
and patients with TAV. Thus, ascending aortic aneurysm
formation in patients with TAV, in contrast to patientsThe Journal of Thoracic and Cawith BAV, is partly influenced by inflammation and immune
response,18 which implies that the underlying molecular
mechanisms of aneurysm formation of the ascending and
descending aortas are similar in patients with TAV but differ
in patients with BAV.
The relative contribution of ascending aortic blood flow
changes to BAV-associated aortic dilatation has been ad-
dressed by numerous studies with partly conflicting results.
A morphologically normal BAV may cause turbulent flow
resulting in aortic dilatation,19 and BAV phenotype per se
has been shown to evoke abnormal helical flow patterns in
the ascending aorta.20 This may support the findings of aor-
tic aneurysm in patients with BAVwith functionally normal
valves.21,22 However, progressive aortic dilatation begins
early in childhood in patients with BAV,23 and a clear corre-
lation of valve pathology and aortic dimensions has not been
shown.24,25 Moreover, the morphology of the aortic root
and ascending aorta is similar regardless of valvular
morphology (ie, BAV or TAV), as well as BAV
phenotype.8 In addition, the lack of detectable differences
in dimensions of the aortic root and ascending aorta between
patients with TAV and patients with BAV, and within the
BAV group alone, in the present cohort does not support al-
tered hemodynamics as the primary cause of aortic dilata-
tion in patients with BAV. The underlying mechanisms of
aneurysm formation need to be further evaluated, preferably
taking valve morphology (BAV/TAV), localization of the
aneurysm (ascending, arch, descending, abdominal), and
aortic valve pathology (stenosis, regurgitation) into account.Study Limitations
The present study group represents a limited cohort ac-
cepted for surgery because of ascending aortic dilatation
and with variations in valve phenotype and pathology;
therefore, the findings may not be applicable to a general,
healthy population with BAV. As previously shown,8 aortic
valve stenosis is rare in patients with TAV with a dilated as-
cending aorta, and this should be taken into account when
interpreting the results. However, the patients represent a de-
fined group subjected to a standardized preoperative exam-
ination interpreted by an external and blinded radiologist.CONCLUSIONS
In patients undergoing surgery for ascending aortic dila-
tation, patients with BAV consistently showed smaller
dimensions of the remaining aorta compared with patients
with TAV. The pattern of cusp fusion and valve function
did not influence the aortic dimensions in patients with
BAV. Concomitant dilatation of the descending aorta was
predominantly found in patients with TAV. Therefore, the
present results may be used to reassure patients with BAV
of a small likelihood of a pathologically dilated remaining
aorta when undergoing surgery of the ascending aorta.rdiovascular Surgery c Volume 146, Number 3 609
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